Mapping high-risk areas for HIV prevention among people who inject drugs in Baltimore
A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland
This study is looking to find areas in Baltimore where people who inject drugs are getting HIV and Hepatitis C the most, so we can understand their behaviors and help create better support and prevention strategies for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11122187 on NIH RePORTER |
What this research studies
This research aims to identify geographic hotspots in Baltimore where high rates of HIV and Hepatitis C infections occur among people who inject drugs (PWID). Using web-based mapping technology, the study will document risk behaviors and the characteristics of injection settings. Additionally, the research will involve collecting and testing drug preparation containers for HIV and HCV antibodies to better understand transmission risks. By engaging 600 participants, the study will gather valuable data over two years to inform targeted interventions aimed at reducing HIV and HCV transmission.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are either HIV positive or negative, particularly those residing in Baltimore.
Not a fit: Patients who do not inject drugs or those living outside of the Baltimore area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for preventing HIV and Hepatitis C infections among vulnerable populations.
How similar studies have performed: Previous research has shown success in using geospatial analysis and targeted interventions to reduce HIV transmission in similar populations.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Latkin, Carl a — Johns Hopkins University
- Study coordinator: Latkin, Carl a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.